Our laboratory has examined the effect of E2 responsiveness in the mouse uterus (27) (28) (29) . Previously, we reported that E2 induces the expression of cell proliferation-related genes similar to different growth factors in the ovariectomized (OVX) mouse uterus (29) . In our microarray gene profile obtained from the E2-treated OVX mouse uterus, we found that the Bop1 mRNA, a proliferation-related factor, is induced, whereas the level of Scx mRNA, a differentiating cell factor, is decreased simultaneously. In this report, we demonstrate a mechanism of reciprocal regulation of Bop1 and Scx gene expression.
EXPERIMENTAL PROCEDURES
Plasmid Construction-The pTRE-c-Myc plasmid was constructed as follows. pCMV-SPORT6-mouse 3962047 plasmid that contains full-length mouse c-Myc cDNA (ATCC, Manassas, VA) was cut with EcoRI and XhoI, and the excised fragment (1.4 kb) was cloned into pCR2.1 vector (Invitrogen) at EcoRI and XhoI sites (pCR2.1-c-Myc). The XbaI fragment (1.4 kb) from pCR2.1-c-Myc plasmid was cloned into pTRE vector (Clontech) at the XbaI site. The direction of the inserted fragment was confirmed by digestion with EcoRI and EcoRV. pTRE-mBop1-cDNA plasmid was constructed as follows. pCMV-SPORT6-mouse 4193123 plasmid that contains fulllength mouse Bop1 cDNA (ATCC) was cut with SacII and XbaI, and the excised fragment (2.5 kb) was cloned into pTRE vector at the SacII and XbaI site. CMV-Scx-cDNA plasmid was constructed as follows. pCMV-SPORT6.1-mouse 30138970 plasmid that contains full-length mouse Scx cDNA (ATCC) was cut with EcoRV and NotI, and the excised fragment (1.1 kb) was cloned into pcDNA3 vector (Invitrogen) at the EcoRV and NotI site. To construct the CMV-Scx-gDNA(ϩ1) and CMV-ScxgDNA(Ϫ250) plasmids, SKA3SH8Z11NA1 plasmid (30) that contains ϳ11 kb of mouse Scx genomic DNA was used (kindly given by Dr. A. Perez, Center for Functional Genomics University at Albany). The DNA fragment (ϩ1 to ϩ2392) and DNA fragment (Ϫ250 to ϩ2392), respectively, of Scx gene were cloned into the pcDNA3 vector. All plasmids were confirmed by sequencing (NIEHS sequencing core).
Animals and Treatments-All animals were handled according to National Institutes of Health guidelines and in compliance with an NIEHS, National Institutes of Health-approved animal protocol. OVX C57BL/6 mice were purchased from Charles River Laboratories (Raleigh, NC). Groups of animals (six mice per group) were treated with sesame oil vehicle (Sigma-Aldrich) or with 1 g of E2 (Steraloids, Newport, RI), either dissolved in 100 l of sesame oil and injected subcutaneously (6-, 12-, and 24-h groups) or dissolved in 100 l of normal saline and injected intraperitoneally (0.5-, 1-, and 2-h groups) before necropsy. In some cases, animals (four mice per group) were treated with 45 g of ICI 182,780 (ICI; Zeneca Pharmaceuticals, Cheshire, UK) that was dissolved in 50 l of dimethyl sulfoxide and injected intraperitoneally, 30 min before E2 injection. Animals were euthanized at the indicated times using CO 2 , and uteri were collected and stored at Ϫ80°C until use.
In Situ Hybridization-Uterine tissue was fixed in 4% paraformaldehyde and then embedded in paraffin before sectioning. Probes that corresponded to the mouse Bop1 and Scx genes were amplified by PCR using the following primers: Bop1 gene (AK079627), 5Ј-CCA TGC CGA GTC TTA CAA CCC ACC-3Ј (nucleotides 913-936) and 5Ј-AGC AGC AAC ACG GCA TCA TCC ATG GC-3Ј (reverse complement to nucleotides 1431-1406); Scx gene (BC062161), 5Ј-ACA CCC AGC CCA AAC AGA TCT GCA C-3Ј (nucleotides 615-639) and 5Ј-CCA GGT AGA GAG CCA GCA TGG AAA GTC-3Ј (reverse complement to nucleotides 960 -934). A 570-bp length of plant-derived sequence (57.9% of guanine-cytosine content) was used for negative control (GENOSTAFF, Tokyo Japan). Probes (cRNA) labeled with digoxigenin were hybridized to the uterus tissue sections, and this procedure was followed by treatment with anti-digoxigenin alkaline phosphatase-conjugated antibodies and visualization by 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (GENOSTAFF).
Establishment of Stable Transformants-C2C12 mouse myoblasts (ATCC) were maintained in Dulbecco's modified Eagle's medium (DMEM; Invitrogen) with 10% fetal bovine serum (FBS; Gemini Bio-products, West Sacramento, CA), 1000 units/ml penicillin, and 1000 g/ml streptomycin. Cells were cultured at 37°C under a 5% CO 2 , 95% air atmosphere. Tet-On-C2C12 was established as follows. C2C12 cells were seeded in a 60-mm diameter dish for transfection. Transfection was performed by using FuGENE 6 (Roche Diagnostics) according to the manufacturer's protocol. pTet-On vector (Clontech) was transfected into the C2C12 cells. The cells were switched to fresh medium with 400 g/ml G418 at 24 h after transfection. The medium was changed every 4 days for 3 weeks. To establish the Tet-On-Myc-C2C12 and Tet-On-mBop1cDNA-C2C12, Tet-On-C2C12 cells were transfected with pTK-Hyg (Clontech) and pTRE-c-Myc or pTRE-mBop1-cDNA plasmids. To select for stable cell lines, the cells were cultured with 300 g/ml G418 and 300 g/ml hygromycin for 2 weeks. BALB/ 3T3 clone A31 mouse fibroblasts (ATCC) were maintained in DMEM with 10% newborn calf serum (Invitrogen), penicillin, and streptomycin. To establish the CMV-Scx-gDNA-BALB/3T3 and CMV-Scx-cDNA-BALB/3T3 cells, CMV-ScxgDNA(ϩ1), CMV-Scx-gDNA(Ϫ250), or CMV-Scx-cDNA plasmids, respectively, were transfected to BALB/3T3 cells. The cells were cultured with 400 g/ml G418 for 3 weeks to select the stable cell line.
Cell Culture and Treatments-Tet-On-Myc-C2C12 and Tet-On-mBop1cDNA-C2C12 cells were maintained in DMEM with 10% FBS, penicillin, streptomycin, 300 g/ml G418, and 200 g/ml hygromycin. Tet-On-Myc-C2C12 cells (1.2 ϫ 10 6 cells) were plated into 100-mm diameter dishes. Two days after, cells (90 -95% confluent) were switched into DMEM with 1% FBS, penicillin, streptomycin, G418, and hygromycin that was subsequently changed every 2 days. Five days after (time 0), the cells were switched to DMEM with 10% FBS, 1 mg/ml doxycyclin, penicillin, streptomycin, G418, and hygromycin. The cells were harvested to collect RNA at 2 or 6 h after changing the medium. Transformed BALB/3T3 cell lines were maintained in DMEM with 10% newborn calf serum, penicillin, streptomycin, and G418. The cells (1.7 ϫ 10 5 cells/well for CMV-ScxgDNA(ϩ250), 1.7 ϫ 10 5 cells/well for CMV-Scx-gDNA(ϩ1), and 1.9 ϫ 10 5 cells/well for CMV-Scx-cDNA) were plated in a 6-well plate. The cells were cultured in the DMEM with 10% newborn calf serum for 24 h and then switched into the DMEM with 1% horse serum (Invitrogen) for 3 days (low serum medium condition) to maintain quiescent cells. To induce the proliferation of the cells, three wells were switched to DMEM with 10% FBS (high serum medium). The other three wells were replaced with fresh low serum medium. The cells were harvested 6 h after changing the medium for RNA extraction.
RNA Extraction and Reverse Transcription-Frozen uterine tissue was pulverized, and total RNA was extracted by using TRIzol reagent (Invitrogen) according to the manufacturer's protocol. Total RNA of the cells was extracted by using a Qiagen RNeasy kit (Qiagen, Valencia CA) according to the manufacturer's instructions. Extracted RNA was treated with TURBO DNase (Ambion) to remove the genomic DNA contamination. To make the cDNA samples, total RNA (1 g) was incubated in 20-l reaction mixes containing 2 l of 10ϫ RT buffer (200 mM Tris-HCl (pH 8.4), 500 mM KCl) (Invitrogen), 100 ng of random hexamer, 0.5 mM dNTPs, 5 mM MgCl 2 , 10 mM dithiothreitol, 40 units of RNaseOUT (Invitrogen), 50 units of SuperScript II reverse transcriptase (Invitrogen) at 42°C for 50 min.
Quantitative PCR-Real-time PCR was performed by using the primer sets as described in Table 1 . To amplify the mRNA, forward and reverse primers were designed on the different exonic sequences except the primers for Bop1 introns. The primers of ScxQ-F and ScxQ-R are localized on the exons 1 and 2, respectively, of the Scx gene. The Bop1Q-F primer is localized on the junction of exons 3 and 4 of the Bop1 gene, and the Bop1Q-R primer is localized on the Bop1 exon 5. The primer mix of Classic II 18 S Standards (Ambion) was used for 18 S ribosomal RNA (18 S). For cDNA amplification, 1-10 ng of cDNA were combined with 25 l of a mixture containing Power SYBR Green PCR master mix (Applied Biosystems, Foster City, CA) and 160 nM forward and reverse primers for Scx (ScxQ), Bop1 (Bop1Q), c-Myc, and Bop1 introns A, B, and C or 26 nM primer mix for 18 S. Samples were analyzed in triplicate. Amplification was carried out as follows: 50°C for 1 min, 95°C for 10 min, and 40 cycles of 95°C for 15 s and 60°C for 1min. To determine the cycle time for each gene, the ABI PRISM 7900 sequence detection system (Applied Biosystems) and SDS 2.1 analysis software (Applied Biosystems) were used. We used the mathematical model described by Pfaffl (31) to get the relative expression levels. 18 S was used as an internal control for all reactions.
PCR-PCR was performed using the primer sets as described in Table 1 . The PCR of Scx was run for 26 or 32 cycles (95°C for 30 s, 66°C for 50 s, and 72°C for 2 min), the PCR of Bop1 was run for 22 cycles (95°C for 30 s, 66°C for 50 s, and 72°C for 2 min), the PCR of 18 S rRNA was run for 14 cycles (95°C for 30 s, 64°C for 50 s, and 72°C for 4 min), and the PCR of Bop1 introns (A, B, and C) was run for 28 cycles (95°C for 30 s, 64°C for 50 s and 72°C for 2 min) using Platinum Taq DNA polymerase (Invitrogen). Aliquots (6 l) of PCR products were resolved on 2% (w/v) agarose gels stained with ethidium bromide and viewed using the UVP, LLC bioimaging system. 
Statistical Analysis-Statistical analysis was performed with two-tailed paired t tests, and p Ͻ 0.05 was considered statistically significant.
RESULTS

The Expression of Bop1 and Scx Genes Is Reciprocally
Regulated-OVX adult female mice were treated with E2 at time 0, and total RNA was isolated at the times indicated (Fig.  2) . Relative amounts of Bop1 and Scx mRNAs were quantified by real-time PCR and normalized with the amount of 18 S as an internal control. As shown in Fig. 2 by the solid lines, E2 stimulated a 6-fold peak of increase (ϩ0.64 as log 10 ratio) in Bop1 mRNA following a 6-h exposure, and the mRNA level was gradually reduced until 24 h. In contrast, the level of Scx mRNA was decreased ϳ80% (Ϫ0.59 as log 10 ratio) at 6 h after E2 treatment and gradually recovered by 24 h. These results indicated that the expression of Bop1 and Scx mRNAs was reciprocally regulated by E2 in the OVX mouse uterus. Additionally, we determined the effect of E2-mediated transcriptional activation on the Bop1 and Scx gene expression using ICI, an estrogen receptor (ER) antagonist that prevents ER-E2-mediated transcription (32) . As shown in Fig. 2 by the dashed lines, ICI attenuated the Bop1 gene activation while also attenuating the down-regulation of the Scx gene expression. These results suggested that E2-activated transcription of the Bop1 gene may be coordinately related to the Scx gene down-regulation.
Antisense RNA for the Scx Gene Is Present in the OVX Mouse Uterus-In situ hybridization (ISH) was performed using the OVX mouse uterus to localize which uterine cells express the Scx and Bop1 transcripts. The signals for the antisense probes of Scx and Bop1 transcripts were detected in the endometrial epithelial cells (Fig. 3A, panels a, b, e, and f) . Interestingly, the signal for the sense probe of the Scx transcript was also detected in the endometrial epithelial cells (Fig. 3A, panels c and d) . These results suggest that the antisense RNA for the Scx gene is present in the uterine cells that express Scx and Bop1 mRNAs. To confirm the existence of the antisense RNA for the Scx gene, RT-PCR was performed using RNA extracted from OVX mouse uteri. As depicted in Fig. 1 , primer set A amplifies a region of intron 3 of the Bop1 gene that does not overlap with the Scx gene. Primer set B amplifies a region of intron 3 that overlaps with the Scx gene, and primer set C amplifies the intron 2 region of the Bop1 gene. We used templates that were synthesized with or without reverse transcriptase (Fig. 3B, ϩRT and ϪRT, respectively) to verify negligible amounts of genomic DNA contamination. No appreciable signal was detected in the ϪRT samples, demonstrating that the amplified fragments from the ϩRT samples were derived from RNA and not genomic DNA contamination (Fig. 3B) . The size of the amplified fragment is identical to the amplicon from mouse genomic DNA, suggesting that the antisense RNA for the Scx gene, which is derived from the Bop1 intron, is present in the mouse uterus. The amount of Bop1 intron 3-and 2-derived RNA was increased at 2 h after E2 treatment, which is prior to the accumulation of Bop1 mRNA (Fig. 3, B and C) . Scx mRNA was decreased at 2 h after E2 treatment, which coincides with the accumulation of Bop1 intron-derived RNA.
The Induction of the Endogenous Bop1 Gene Correlates with the Down-regulation of the Scx mRNA Level in Tet-On-Myc-C2C12
Cells-To examine the effect of Bop1 gene activation on the Scx gene down-regulation in an estrogen-independent manner, we established an in vitro model using C2C12 myoblasts, a murine cell line reported to express endogenous Scx mRNA (33) . Several reports indicate that the Bop1 gene expression is induced by c-Myc (34). To activate endogenous Bop1 gene expression, we established a Tet-On-Myc C2C12 cell line that contains a tetracycline (Tet)-mediated transcription activator (TetR) expression vector and a TetR binding element fused to a c-Myc expression vector. Cells were stimulated by a Tet derivative compound, doxycycline, and harvested 6 h after stimulation. Fig. 4A shows that c-Myc mRNA was stimulated by the treatment (3.4-fold) and that Bop1 mRNA was also increased by 1.6-fold (ϩ0.21 as log 10 ratio). In contrast, Scx mRNA was decreased 30% (Ϫ0.12 as log 10 ratio) 6 h after treatment. Samples were harvested 2 h after treatment to evaluate the expression level of Bop1 intron-derived RNA in this system. As shown in Fig. 4 , B and C, Bop1 intron-derived RNA is increased by 2 h after treatment.
Additionally, a Tet-On-mBop1-cDNA C2C12 cell line that expresses the mature Bop1 mRNA, which does not contain intronic sequences, was established to evaluate the involvement of Bop1 intronderived RNA in the down-regulation of the Scx mRNA level. Fig. 4D shows that Bop1 mRNA was induced by doxycycline treatment after 6 h (1.5-fold); however, the level of Scx mRNA did not change after Bop1 mRNA accumulation, suggesting the need for Bop1 intronic RNA and not mRNA in Scx gene down-regulation.
Down-regulation of Scx mRNA Occurs via a Trans-acting Mechanism-The findings above suggested that the accumulation of Bop1
intron-derived RNA is related to the reduction of the Scx mRNA level. Therefore, we examined whether the Bop1 intronic RNA leads to the down-regulation of the Scx gene in a trans-acting manner. The murine fibroblast BALB/3T3 cells were used for this experiment because these cells do not express the endogenous Scx mRNA and can be induced to express endogenous Bop1 by serum stimulation (15) . We established the BALB/3T3 cell lines that express Scx mRNA from the CMV promoter fused to the Scx genomic DNA that contains ϩ1 to ϩ2309 sequence of the Scx gene (CMVScx-gDNA(ϩ1)), Ϫ250 to ϩ2039 sequence of the Scx gene (CMV-ScxgDNA(Ϫ250)), or full-length Scx cDNA (CMV-Scx-cDNA) (Fig. 5A) . Initially, we examined the transcripts expressed from the Scx genomic DNA and Scx cDNA by RT-PCR. The 409-bp amplicon corresponding to mature Scx mRNA was detected as the major transcript in these cell lines. The amplicon corresponding to premature Scx mRNA (1304 bp) was undetectable in the CMV-Scx-gDNA cell lines. No amplicon was detected in the empty pcDNA3 transfected cell line or in the ϪRT samples, suggesting that this transcript is expressed from the transfected gene (Fig. 5B) . The cells were cultured in low serum medium for 3 days to reduce the endogenous Bop1 expression level. Bop1 was induced in these cells by changing to high serum medium, and the cells were harvested 6 h after changing the medium for RNA extraction. As shown in Fig. 5C , Scx mRNA decreased 40% 6 h after treatment in the CMV-Scx-gDNA(Ϫ250) cell line, whereas the level of Scx mRNA did not change in the CMV-Scx-gDNA(ϩ1) and CMV-Scx-cDNA cell lines. The premature Scx mRNA was not detected in these cells with or without treatment (data not shown). The levels of Bop1 mRNA and Bop1 intron-derived RNA (primer set A) increased 6 h after changing to high serum medium in this system (Fig. 5, D and E) . Taken together, these results suggest that Bop1 intronic RNA impairs the Scx gene transcription and acts in a trans-acting manner.
DISCUSSION
Although gene profiling studies both in vivo and in vitro show that hormones stimulate and repress gene expression, the mechanisms for estrogen-mediated gene down-regulation are not extensively studied and are poorly understood. Down-regulation of gene expression related to the arrangement of overlapping genes on opposing strands, as a potential mechanism, is thought to be due to transcriptional interference, RNA masking, and/or RNA interference (35, 36) . In the transcriptional interference model, because transcription by RNA polymerase II involves both large protein complexes and the unwinding of duplex DNA, it is unlikely that two overlapping transcriptional units could be transcribed concomitantly. Thus, for example, the transcript from the initiator element, which is in the first intron of the eIF2␣ gene on the opposing strand, decreases eIF2␣ transcription (37, 38) . In the RNA-masking mechanism, formation of RNA duplexes between sense and antisense transcripts occurs and then inhibits the binding of trans-acting factors to the regulatory features of the transcripts. This form of steric inhibition could affect steps involved in mRNA splicing, transport, polyadenylation, translation, and degradation. As an example of this mechanism, the TR␣ gene encodes TR␣1 as well as an alternatively spliced product, TR␣2. The RevErbA␣ gene, which is transcribed from the opposite direction from the same locus, overlaps the TR␣2 coding region. The ratio of TR␣1 and TR␣2 expression level is modified by the RevErbA␣ gene posttranscriptionally (39) . In the RNA interference mechanism, formation of RNA duplexes leads to gene silencing via RNA interference pathways. Double strand RNA is potentially cleaved by the Dicer enzyme into 21-23-nucleotide duplexes (small inter- fering RNA). These fragments may target the specific destruction of homologous RNA (40) or silence the gene expression epigenetically (41) . In this report, we show that the level of Scx mRNA expressed from the exogenous Scx genomic DNA, which contains the Scx gene promoter (CMV-Scx-gDNA(Ϫ250)), reduced as Bop1 intron-derived RNA accumulated. The Scx mRNA levels expressed from genomic DNA and cDNA without the Scx gene promoter (CMV-Scx-gDNA(ϩ1) and CMV-Scx-cDNA) were not affected by Bop1 intronic RNA accumulation. This Scx gene promoter region, between Ϫ250 to ϩ1, harbors two TATA boxes that are involved in Scx gene transcription initiation (supplemental Fig. S1 ). This result suggests that the reduction of the Scx mRNA level is due at least in part to the inhibition of Scx gene transcription. Additional detail of the antisense RNA-mediated Scx gene transcription repression will need to be assessed in future studies.
We attempted to identify a negative estrogen-responsive element in the 5Ј-flanking region (Ϫ7 kb) of Scx. Examination by reporter analysis did not reveal negative regulatory elements in this region; however, a potential ER-E2-mediated positive regulatory element was found (supplemental Fig. S2 ). ER-E2-mediated enhancement of the initiation of Scx gene transcription might be inhibited by Bop1 intronic RNA, although further investigation is needed to confirm this hypothesis.
Two different Scx knock-out mouse lines are reported, and both indicate the importance of intron 3 of the Bop1 gene with regard to Scx gene expression (21, 23) . Both knock-out mice were targeted in a similar genomic position, namely a Neo cassette was inserted into exon 1 of the Scx gene to disrupt the expression of Scx mRNA (23) or an FRT-Neo cassette was inserted into the intron of the Scx gene flanking the first exon, allowing removal of the Scx exon 1 using the cre-loxP system (21) . Retention of the Neo cassette in this genomic region in both mice lead to embryonic lethality due to the inhibition of cell proliferation between embryonic day 6.0 and embryonic day 6.5 (23) , which indicates that this genomic region may be important for correct Bop1 expression. On the other hand, the deletion of Scx exon 1 (about 500 bp) is not embryonic lethal (21) . Our ISH and RT-PCR analyses showed that the Bop1 intronic RNA corresponding to this region exists stably, and our in vitro studies showed that the accumulation of Bop1 intronic RNA impairs the Scx gene expression in a trans-acting manner, causing the reduction of the mRNA level. Bop1 intronic RNA, overlapping with the Scx gene, may be a coordinate means by which a mitogenic stimulus such as estrogen invokes an increase in a proliferation gene (Bop1) while simultaneously suppressing a differentiation gene (Scx) to facilitate the biological action. Further evaluation of other gene pairs will be needed to determine the broadness of this type of regulation and possible application to the hormonal responsiveness in this and other tissues.
